Patents by Inventor Darren Peter Medland

Darren Peter Medland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3,5-DISUBSTUTUTED 1H-PYRROLO [2,3-B] PYRIDINES AS JNK INHIBITORS
    Publication number: 20110166173
    Abstract: The present invention provides novel compounds of forumula (I) and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Application
    Filed: March 3, 2005
    Publication date: July 7, 2011
    Applicant: Eisai Co., Ltd.
    Inventors: Darren Peter Medland, Piotr Pawel Graczyk, Gurpreet Singh Bhatia
  • INHIBITORS OF C-JUN N-TERMINAL KINASES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS RELATING TO APOPTOSIS AND/OR INFLAMMATION
    Publication number: 20100035878
    Abstract: The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Application
    Filed: October 6, 2009
    Publication date: February 11, 2010
    Applicant: EISAI R & D MANAGEMENT CO., LTD.
    Inventors: Afzal KHAN, Darren Peter MEDLAND, Gurpreet BHATIA
  • Inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation
    Patent number: 7645769
    Abstract: The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Grant
    Filed: August 4, 2006
    Date of Patent: January 12, 2010
    Assignee: Eisai R & D Management Co., Ltd.
    Inventors: Afzal Khan, Darren Peter Medland, Gurpreet Singh Bhatia
  • Jun kinase inhibitors
    Patent number: 7314940
    Abstract: The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: January 1, 2008
    Assignee: Eisai Co., Ltd.
    Inventors: Piotr Graczyk, Hirotoshi Numata, Afzal Khan, Vanessa Palmer, Darren Peter Medland, Hitoshi Oinuma, Gurpreet Bhatia
  • Azaindoles as inhibitors of c-Jun N-terminal kinases
    Patent number: 7291630
    Abstract: The present invention relates to novel 5-substituted 7-azaindole compounds of formula (I), their use in the inhibition of c-Jun N-terminal kinases, their use in medicine and particularly in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: November 6, 2007
    Assignee: Eisai Co., Ltd.
    Inventors: Piotr Graczyk, Hirotoshi Numata, Gurpreet Bhatia, Darren Peter Medland
  • Jun kinase inhibitors
    Publication number: 20040235864
    Abstract: The present invention provides novel compounds of formula I 1
    Type: Application
    Filed: April 23, 2004
    Publication date: November 25, 2004
    Inventors: Piotr Graczyk, Hiroshi Numata, Afzal Khan, Vanessa Palmer, Darren Peter Medland, Hitoshi Oinuma, Gurpreet Bhatia